Asthma is a disease of the lungs that affects people of all ages and both sexes. About 1 in 13 people in the United States ...

A year ago, he became one of just 200 people selected to take part in the trial of a new asthma treatment, Benralizumab, that ...

The study highlights T2-low and T17-high asthma endotypes in minoritized youths, offering insights for precision medicine and ...

Here are four drug and biotech stocks, ARQT, MESO, MNPR and KOD, which have more than doubled in 2024 with room for further ...

Accordingly, co-author Chun-Tse Hung, PharmD, also of Taipei Medical University ... should consider cost, not just treatment effects, when prescribing asthma medication. Researchers used data ...

The study offers promising solutions ... First New Treatment for Asthma Attacks in 50 Years Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more ...

A mother who neglected to bring her daughter to the hospital for hours during an asthma attack has been sentenced to serve ...

The tool, developed by researchers at Pitt, could allow doctors to diagnose subtypes of the disease without putting patients ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), according to a study published online Nov. 27 in The ...

According to a recent study, financial constraint was a major contributor to nonadherence to medications in adults with asthma in the United States.

But if this is true, then nearly 1 in 5 in our community should have asthma treatment on hand during ... for thunderstorm asthma alongside a robust medical approach to identify and treat that ...